Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Carcinoma, Intraductal, Noninfiltrating 2 Breast Diseases 2 Advanced Breast Cancer 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunctions, Psychological 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HER2 Negative Breast Cancer 1 Endometrial Neoplasms 1 Breast Neoplasms, Male 1 Breast Neoplasm Female 1 Breast Carcinoma In Situ 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

exemestane 2 Letrozole 2 ribociclib 1 elacestrant 1 Taxes 1 Tamoxifen 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Leuprolide 1 Immunotherapy 1 Goserelin 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Anastrozole × 30 days × Clear all

NCT06492616 2026-05-27

ELEGANT

Stemline Therapeutics, Inc.

Phase 3 Recruiting

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡